Solutions — Clinical Trials
Sensitive, longitudinal digital endpoints
Detect functional change earlier and with more resolution than episodic assessment. The same measurement infrastructure that runs in real-world care provides repeated, multimodal endpoints designed for analysis and regulatory scrutiny.
Earlier signal
Repeated multimodal measurement captures trajectory between visits, where meaningful change unfolds.
Higher resolution
Continuous, multi-system signals replace coarse pass/fail cutoffs with nuanced longitudinal trajectories.
Analysis-ready
Structured, quality-controlled data is built for statistical analysis and regulatory review.
Capabilities
What it delivers
Repeated multimodal measurement
Collect cognitive, behavioral, neuromotor, and physiological signals across the study timeline.
Anchor-linked endpoints
Digital measures are linked to validated clinical anchors — complementing, not replacing, established endpoints.
Quality controls
Signal-quality checks and standardized capture reduce missing data and site-to-site variability.
Auditable data
Structured outputs and traceable processing support transparent, reproducible analysis.
Use cases
Where it applies
- Longitudinal cognitive endpoints in neurodegeneration studies
- Sensitivity analyses for early functional change
- Remote and decentralized measurement components
- Exploratory digital biomarkers alongside validated anchors
All research, patient access, data use, and study activity remain subject to project-specific agreements, institutional approvals, privacy requirements, and IRB review.